These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1346095)

  • 1. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides.
    Wun TC
    Blood; 1992 Jan; 79(2):430-8. PubMed ID: 1346095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.
    Wun TC; Huang MD; Kretzmer KK; Palmier MO; Day KC; Bulock JW; Fok KF; Broze GJ
    J Biol Chem; 1990 Sep; 265(27):16096-101. PubMed ID: 2168880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
    Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP
    Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
    Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
    Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.
    Girard TJ; MacPhail LA; Likert KM; Novotny WF; Miletich JP; Broze GJ
    Science; 1990 Jun; 248(4961):1421-4. PubMed ID: 1972598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation.
    Lindahl AK; Abildgaard U; Larsen ML; Aamodt LM; Nordfang O; Beck TC
    Thromb Res Suppl; 1991; 14():39-48. PubMed ID: 1658969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
    Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
    Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor.
    Lindahl AK; Abildgaard U; Staalesen R
    Thromb Res; 1991 Oct; 64(2):155-68. PubMed ID: 1811336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor.
    Gemmell CH; Broze GJ; Turitto VT; Nemerson Y
    Blood; 1990 Dec; 76(11):2266-71. PubMed ID: 2257300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of synthetic pentasaccharide, low-molecular-weight heparin, unfractionated heparin and recombinant hirudin on the generation of factor VIIa and prothrombin activation after coagulation of human plasma.
    Gerotziafas GT; Bara L; Bloch MF; Makris PE; Samama MM
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):571-80. PubMed ID: 9863704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
    Fernández JA; Petäjä J; Griffin JH
    Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.
    Novotny WF; Girard TJ; Miletich JP; Broze GJ
    J Biol Chem; 1989 Nov; 264(31):18832-7. PubMed ID: 2553722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous presence of tissue factor pathway inhibitor (TFPI) and low molecular weight heparin has a synergistic effect in different coagulation assays.
    Valentin S; Ostergaard P; Kristensen H; Nordfang O
    Blood Coagul Fibrinolysis; 1991 Oct; 2(5):629-35. PubMed ID: 1664252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor.
    Novotny WF; Palmier M; Wun TC; Broze GJ; Miletich JP
    Blood; 1991 Jul; 78(2):394-400. PubMed ID: 2070077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.